StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultMar 29, 2026, 10:42 PM

Abbott Laboratories Announces Q4 and Full Year 2025 Results

AI Summary

Abbott Laboratories announced its Q4 and full year 2025 results on January 22, 2026. The company's management believes the presentation of non-GAAP financial measures provides useful information to investors regarding Abbott’s results of operations, allowing investors to better evaluate ongoing business performance.

Key Highlights

  • Abbott announced Q4 and full year 2025 results.
  • The company uses non-GAAP financial measures, excluding items like acquisition expenses, restructuring actions, and intangible amortization.
  • Management believes non-GAAP measures provide useful information for investors to evaluate ongoing business performance.